Citation Impact
Citing Papers
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
2016
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
2016
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes
1997
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
2017
Metabotropic glutamate receptor 5: a target for migraine therapy
2016
Impact of Long-Term Ranitidine and Pantoprazole on Accuracy of [13C]Urea Breath Test
2003
Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects
2018
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
2016
The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome
2016 Standout
G protein coupled receptor structure and activation
2006 StandoutNobel
Contribution of platelets to tumour metastasis
2011 Standout
Sleep and Alzheimer disease pathology—a bidirectional relationship
2013
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
The glymphatic pathway in neurological disorders
2018 Standout
CGRP as the target of new migraine therapies — successful translation from bench to clinic
2018
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
2011
Systematic Review and Meta‐analysis from Chinese Literature: the Association Between Helicobacter pylori Eradication and Improvement of Functional Dyspepsia
2007
The problem of choice: current biologic agents and future prospects in RA
2013
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
2014
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest
2007
Helicobacter pyloriin Peptic Ulcer: Have Koch's Postulates Been Fulfilled?
1995
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Discovery and characterization of olokizumab
2014
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Understanding the mechanisms and treatment options in cancer cachexia
2012
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2017
Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors
2012
Cancer-associated cachexia
2018 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads
2012
Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs
2007 StandoutNobel
A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis
1994
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)
2009
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Calorie restriction in rodents: Caveats to consider
2017
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
1995
Muscle wasting in disease: molecular mechanisms and promising therapies
2014
Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion
2003
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
How to fix a broken clock
2013
Role of Activin A and Myostatin in Human Cancer Cachexia
2015
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
2014
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori–infected healthy subjects
1998
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
2018
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
2014
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Sequential Binding of Agonists to the β2 Adrenoceptor
2003 StandoutNobel
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
2019
Activation of G Protein–Coupled Receptors
2007 StandoutNobel
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
2012
Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
2015
The actions of bismuth in the treatment of Helicobacter pylori infection
1997
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Biological metals and metal-targeting compounds in major neurodegenerative diseases
2014
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
2008 StandoutNobel
A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects
1998
Metalle in der Medizin
1999
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
2003 StandoutNobel
The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer
2013
Toxic effects of metals
1991 Standout
Cancer, Clots and Consensus: New Understanding of an Old Problem
2009
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines
2018
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
2011
Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring
1999
Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.
1996
The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
2017
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
Pharmacokinetics and Toxicity of Bismuth Compounds
1989
Asymmetrische Katalyse mit hinsichtlich Struktur und Funktion gezielt entworfenen Molekülen: die chemo- und stereoselektive Hydrierung von Ketonen
2001 StandoutNobel
A second trigeminal CGRP receptor: function and expression of the AMY 1 receptor
2015
Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling
1998 StandoutNobel
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
2018
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
2001
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of Jeff Smith being referenced
Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
1991
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
1990
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB)
1994
Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease
2012
Restricting feeding to the active phase in middle-aged mice attenuates adverse metabolic effects of a high-fat diet
2016
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
2011
Royal Free Hospital Protocol for 24-Hour Intragastric Acidity and Plasma Gastrin Concentration
1990
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
2014
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
2012
4-Hydroxynonenal disrupts zinc export in primary rat cortical cells
2005
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate
1989
Eradication of Helicobacter pylori abolishes 24‐hour hypergastrinaemia: a prospective study in healthy subjects
1991
Tolerance during 8 days of high‐dose H2‐blockade: placebo‐controlled studies of 24‐hour acidity and gastrin
1990
317 A comparative study of the effects of intranasal triamcinolone acetonide and prednisone on adrenocortical function
1991
Drug-Induced Changes of Plasma Gastrin Concentration
1990
Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized, double-blind safety and efficacy trial.
2010
A phase I, pharmacokinetic (PK), and preliminary efficacy assessment of ALD518, a humanized anti-IL-6 antibody, in patients with advanced cancer
2009
ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.
2010
Thromboprophylaxis in medically ill patients at risk for venous thromboembolism
2006
Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects
1991